[1]
“A randomized, parallel, open-label clinical study comparing the effectiveness and safety of apremilast with methotrexate in individuals with moderate to severe palm plantar psoriasis”., IAJLB, vol. 18, no. 3, pp. 68–79, Jul. 2021, Accessed: Oct. 16, 2026. Available: https://iajlb.org/index.php/iajlb/article/view/124